Cover Image

A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib

Aim: To evaluate the impact of palbociclib treatment on health-related quality of life (HRQoL) in patients with hormone receptor-positive, human epidermal growth factor 2-negative advanced breast cancer (HR+/HER2- aBC) or metastatic breast cancer (mBC) in both the clinical and real-world setting. Ma...

Full description

Saved in:

Bibliographic Details
Main Authors:	Imtiaz A Samjoo (Author), Alexandra Hall (Author), Connie Chen (Author), Bao-Ngoc Nguye (Author), Meaghan Bartlett (Author), Mary Lou Smith (Author), Nadia Harbeck (Author), Joseph C Cappelleri (Author), Meghan Karuturi (Author), Doris Makari (Author), Lillian Shahied Arruda (Author), Rickard Sandin (Author), Kent Hanson (Author), Justin Doan (Author)
Format:	Book
Published:	Becaris Publishing Limited, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Two Novel Palbociclib-Resorcinol and Palbociclib-Orcinol Cocrystals with Enhanced Solubility and Dissolution Rate
by: Chenxin Duan, et al.
Published: (2021)

Palbociclib in the treatment of recurrent ovarian cancer
by: Dai Wee Lee, et al.
Published: (2020)

Palbociclib in breast cancer neoadjuvant setting
by: Sílvia Alexandra Cabral Duarte, et al.
Published: (2021)

Population Pharmacokinetics of Palbociclib in a Real-World Situation
by: Bernard Royer, et al.
Published: (2021)

Oral ulcers in patients treated with palbociclib: a case report
by: Alande Cédric, et al.
Published: (2018)

Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib
by: Zhimin Zhu, et al.
Published: (2023)

Successful Use of Photodynamic Therapy for Treatment of Palbociclib-Induced Periorificial Dermatitis
by: Davide Fattore, et al.
Published: (2024)

Palbociclib in metastatic breast cancer: current evidence and real-life data
by: Francesco Serra, et al.
Published: (2019)

Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients
by: Alexandre Le Marouille, et al.
Published: (2021)

Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy
by: Claudia Arndt, et al.
Published: (2023)

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB - A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER
by: E. N. Imyanitov, et al.
Published: (2017)

Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer
by: Perrine Courlet, et al.
Published: (2022)

Letter to the Editor: statistics and clinical perception of patients' reported outcomes for palbociclib and abemaciclib: a sliding doors story
by: Vittorio Gebbia
Published: (2023)

HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
by: Zhipeng Li, et al.
Published: (2023)

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
by: Elisa Callegari, et al.
Published: (2022)

miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
by: Elisa Callegari, et al.
Published: (2022)

The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter
by: Han Fu, et al.
Published: (2022)

Correction: HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
by: Zhipeng Li, et al.
Published: (2024)

Improve BBB Penetration and Cytotoxicity of Palbociclib in U87-MG Glioblastoma Cells Delivered by Dual Peptide Functionalized Nanoparticles
by: Yu-Chen Lo, et al.
Published: (2023)

Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug-Drug Interactions Are the Usual Suspects
by: Fanny Leenhardt, et al.
Published: (2022)

Pomen komuniciranja z bolnikom oziroma varovancem ob sprejemu v splošno ambulanto
by: Zdenka Makari
Published: (1999)

Evaluating a targeted Palbociclib-Trastuzumab loaded smart niosome platform for treating HER2 positive breast cancer cells
by: Shaghayegh Saharkhiz, et al.
Published: (2024)

Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor Palbociclib: a case report and literature review
by: Shan Gao, et al.
Published: (2023)

PALBOCICLIB IN COMBINATION WITH HORMONE THERAPY FOR LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER: NEW HIGHLY EFFECTIVE STRATEGY OF DRUG TREATMENT
by: E. V. Artamonova
Published: (2017)

Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant
by: Ernest H Law, et al.
Published: (2023)

Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain
by: Galve-Calvo E, et al.
Published: (2018)

Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions
by: Elena Peruzzi, et al.
Published: (2024)

Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
by: Colombo GL, et al.
Published: (2023)

Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR+/HER2- metastatic breast cancer: a prospective, monocentric study
by: Raffaella Palumbo, et al.
Published: (2024)

Sàng khôn as A Theorizing Tool in Mobility Education
by: Ngoc Ba Doan
Published: (2017)

Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcome
by: Khaled Abd Elaziz Ahmed Elnaghi, et al.
Published: (2023)

Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment
by: Lu Turković, et al.
Published: (2022)

SG-APSIC1126: Controlling SARS-CoV-2 infection in inpatients through a grouping system at Ho Chi Minh Children's Hospital 1 in Vietnam
by: Chau Nguyen Ngoc Minh, et al.
Published: (2023)

Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis
by: Imtiaz A Samjoo, et al.
Published: (2023)

Toll 7 and Toll 9 in psoriasis vulgaris before and after phototherapy
by: Doaa Mahgoub, et al.
Published: (2014)

Medical rehabilitation in low and middle income countries for adult acquired disability: challenges posed by rapidity of health system change and position on the individualistic-collectivist axis
by: Karl Sandin
Published: (2015)

Adverse events in women giving birth in a labor ward: a retrospective record review study
by: Annika Skoogh, et al.
Published: (2021)

Healthcare professionals' perceptions of patient safety for the woman in childbirth in Sweden - An interview study
by: Annika Skoogh, et al.
Published: (2020)

Analysis of root coverage esthetic score in patients treated for gingival recession: An interexaminer reliability
by: Inti Srividya, et al.
Published: (2021)

Australia A Cultural History
by: Rickard, John
Published: (2017)